Roy deSouza

Roy de Souza is the CEO and Co-founder of BreakBio, a biotechnology company focused on developing personalised approaches to cancer treatment. BreakBio is working at the intersection of cancer biology, technology and artificial intelligence to identify treatment approaches based on the unique characteristics of an individual patient’s cancer.

A technology entrepreneur and the founder of ZEDO, Roy brings a background in technology and innovation to his work in cancer research. His journey into this field was also deeply personal, following his wife’s experience with cancer and the questions it raised around how cancer treatment could become more individualised.

Through BreakBio, Roy is working towards a different approach to cancer treatment, one that seeks to understand the specific biology of a patient’s tumour and use that information to explore more personalised immunotherapy strategies. His work brings together technology, scientific research and collaboration with researchers and clinicians in the pursuit of new possibilities in cancer care.

At GreySmiles, Roy writes about developments in cancer research, personalised medicine and emerging approaches that could shape the future of cancer treatment.